Stanley Druckenmiller acquired 1.15M Insmed shares worth $125M. That's 3.90% of their equity portfolio (5th largest holding). The first Insmed trade was made in Q2 2020. Since then Stanley Druckenmiller bought shares five more times and sold shares on three occasions. The stake costed the investor $90.4M, netting the investor a gain of 38% so far.